Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May-Jun;26(3):489-94.
doi: 10.1111/j.1399-0012.2011.01543.x. Epub 2011 Oct 27.

Underutilization of A2 ABO incompatible kidney transplantation

Robert R Redfield  1 , Ronald F Parsons, Eduardo Rodriguez, Moiz Mustafa, James Cassuto, Kumar Vivek, Hooman Noorchashm, Ali Naji, Matthew H Levine, Peter L Abt
Affiliations

Underutilization of A2 ABO incompatible kidney transplantation

Robert R Redfield et al. Clin Transplant. 2012 May-Jun.

Abstract

Background: ABO compatibility creates a disadvantage for O and B renal allograft candidates. A2 ABO incompatible transplant may decrease waiting times and generate equivalent graft survival to an ABO compatible transplant.

Methods: Death-censored graft survival was compared between A recipients and O, B, and AB recipients of an A2 allograft with multivariate Cox regression models utilizing data from the United Network of Organ Sharing (UNOS) between 1997 and 2007.

Results: Eighty-five percent of A2 kidneys were transplanted into ABO compatible recipients vs. 15% into ABO incompatible recipients. Rates of A2 incompatible kidney transplants did not increase over the study period (14.8% to 14.6%). Mean wait time for A2→O kidneys was 337 vs. 684 d for O→O and for A2→B kidneys, 542 vs. 734 d for B→B. Adjusted relative risk of graft loss at five-yr was similar between O, B, and AB recipients compared to A recipients of an A2 allograft, corresponding to a five-yr graft survival of 84%, 86.2%, 86.1%, and 86.1%, respectively.

Conclusion: A2 incompatible kidney transplantation is underutilized. Graft outcomes are similar among A2 compatible and incompatible recipients. Shorter waiting time and improved access might be achieved if A2 kidneys are considered in all blood groups.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors report no conflict of interest.

Figures

Fig. 1
Fig. 1
Five year death censored graft survival estimated by Cox regression analysis.
See this image and copyright information in PMC

References

    1. 2009 OPTN/SRTR Annual Report 1999–2008. HHS/HRSA/HSB/DOT.

    1. Glander P, Budde K, Schmidt D, et al. The ‘blood group O problem’ in kidney transplantation – time to change? Nephrol Dial Transplant. 2010;25:198. - PubMed
    1. Kasiske BL, Neylan JF, III, Riggio RR, et al. The effect of race on access and outcome in transplantation. N Engl J Med. 1991;324:302. - PubMed
    1. Breimer ME, Molne J, Norden G, Rydberg L, Thiel G, Svalander CT. Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status. Transplantation. 2006;82:479. - PubMed
    1. Breimer ME, Samuelsson BE. The specific distribution of glycolipid-based blood group A antigens in human kidney related to A1/A2, Lewis, and secretor status of single individuals. A possible molecular explanation for the successful transplantation of A2 kidneys into O recipients. Transplantation. 1986;42:88. - PubMed

Substances